3701-55-02 Required screening; facility requirements.
(A)All newborn children shall be screened in accordance with procedures set forth in this chapter for the presence of the following genetic, endocrine, or metabolic disorders:
(1) Argininosuccinic acidemia;
(2) Citrullinemia;
(3) Congenital adrenal hyperplasia;
(4) Congenital hypothyroidism;
(5) Galactosemia;
(6) Homocystinuria (cystathionine-beta-synthase deficiency);
(7) Isovaleric acidemia;
(8) Maple syrup urine disease;
(9) Medium chain acyl-coA dehydrogenase deficiency;
(10) Methylmalonic acidemia;
(11) Phenylketonuria;
(12) Propionic acidemia; and
(13) Sickle cell and other hemoglobinopathies.
(B)All hospitals and freestanding birthing centers that are required by this chapter to cause specimens to be collected for newborn screening for genetic, endocrine, or metabolic disorders shall:
(1)Designate a newborn screening coordinator and physician responsible for the coordination of the facility's newborn screening;
(2)Notify the chief of the Ohio department of health bureau of public laboratories of the name of the individual designated as the newborn screening coordinator on a yearly basis and whenever the designated individual changes; and
(3)Develop a written protocol for tracking newborn screening. The protocol must include a requirement that the name of the physician attending the child after birth or a designee be placed on the specimen slip sent with the initial specimen to the Ohio department of health public health laboratory.
3701-55-02 2
Replaces:
3701-45-02
Effective:
06/15/2003
R.C. 119.032 review dates:
06/01/2008
CERTIFIED ELECTRONICALLY
Certification
06/05/2003
Date
Promulgated Under: 119.03
Statutory Authority: 3701.501
Rule Amplifies: 3701.501
Prior Effective Dates: None
Document Information
- Effective Date:
- 6/15/2003
- File Date:
- 2003-06-05
- Last Day in Effect:
- 2003-06-15
- Rule File:
- 3701-55-02_PH_FF_N_RU_20030605_0813.pdf
- Related Chapter/Rule NO.: (1)
- Ill. Adm. Code 3701-55-02. Required screening; facility requirements